EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Contribution of xpert MTB/RIF assay and Urine LF-LAM for the diagnosis of tuberculosis in children aged 5 – 14 years, at selected health facilities in Ethiopia, 2016 – 2019

Muluwork Getahun iD, Yenew Kebede, Hilina Molalegn, Ayinalem Alemu, Getu Diriba, Waganeh Sinshaw, Mengistu Tadesse, Ephrem Tesfaye, Kassahun Belachew, Ameha Mekasha, Beniam Feleke

PLOS One · 2025

DOI: 10.1371/journal.pone.0338557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Muluwork Getahun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Ethiopian Public Health Institute, Infectious Disease Research Directorate, Addis Ababa, Ethiopia. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Tuberculosis, Pulmonary. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Childhood tuberculosis (TB) remains under-reported and undiagnosed. A full complement of diagnostic tests is oftentimes unavailable in resource limited country like Ethiopia. This study assesses the contribution of Xpert MTB/RIF assay and urine LF-LAM for childhood TB diagnosis using sputum and urine samples.

Method

A facility based cross-sectional study was conducted in children between 5 and 14 years of age. Sputum and urine samples were collected from children with presumptive TB. The samples were tested for TB using LF-LAM, Xpert MTB/RIF assay, concentrated smear microscopy, and culture. Diagnostic performance of Xpert MTB/RIF assay was analyzed and compared against culture, which was used as the gold standard. Urine LF-LAM test result was compared to a composite reference standard.

Result

Of 576 participants with presumptive TB enrolled in the study, 519 (90.1%) had complete clinical data and bacteriological laboratory test results. Active TB was diagnosed in 14.1% (73/519), and bacteriological confirmation was made in 10.1% (52/515) of children with presumptive TB. The odds of being diagnosed with a bacteriologically confirmed TB are significantly higher in children who have household contact history with TB patient (aOR 2.27, P = 0.03) and age above 10 years (aOR 3.67, P < 0.001). Xpert MTB/RIF test had sensitivity of 79% using culture as the gold standard. Compared to smear microscopy, the sensitivity of the Xpert MTB/RIF assay increased by 50% for children aged 5–9 years and by 40% for children and adolescents living with HIV (C/ALHIV). All bacteriologically confirmed (n = 2) and clinically diagnosed TB children (n = 2) who live with HIV were tested positive for urine LF-LAM. The overall sensitivity of urine LF-LAM was 27.6% when using the composite reference standard, compared to 17.9% when the bacteriological reference standard was applied.

Conclusions

Pulmonary TB diagnosis was greatly improved with the use of Xpert MTB/RIF assay, particularly in children aged 5–9 years and C/ALHIV who typically have difficulty producing good quality sputum. Urine LF-LAM performed well in children/adolescents who tested positive for HIV, but it performed poorly in the other variables, which suggests that urine LF-LAM testing did not play a critical role in TB diagnosis in children with negative HIV status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosisTuberculosis, PulmonaryHumansChildChild, PreschoolEthiopiaAdolescentMaleFemaleCross-Sectional StudiesSputumSensitivity and SpecificityHealth Facilities

Autor:innen und Institutionen

  • Ethiopian Public Health Institute, Infectious Disease Research Directorate, Addis Ababa, Ethiopia.
  • Division of Laboratory Systems & Networks, Africa Centers for Disease Control and Prevention, Addis Ababa, Ethiopia.
  • University of Gondar comprehensive specialized Hospital, Addis Ababa, Ethiopia.
  • Black lion Hospital, Addis Ababa, Ethiopia.
  • Centers for Disease Control and Prevention, Division of Global HIV and TB, Addis Ababa, Ethiopias.

ORCID-Profile: Muluwork Getahun

Förderung

  • FIC NIH HHS

Zitieren

APA

Getahun, M., Kebede, Y., Molalegn, H., Alemu, A., Diriba, G., Sinshaw, W., Tadesse, M., Tesfaye, E., Belachew, K., Mekasha, A., & Feleke, B. (2025). Contribution of xpert MTB/RIF assay and Urine LF-LAM for the diagnosis of tuberculosis in children aged 5 – 14 years, at selected health facilities in Ethiopia, 2016 – 2019. PLOS One. https://doi.org/10.1371/journal.pone.0338557

Vancouver

Getahun M, Kebede Y, Molalegn H, Alemu A, Diriba G, Sinshaw W, et al. Contribution of xpert MTB/RIF assay and Urine LF-LAM for the diagnosis of tuberculosis in children aged 5 – 14 years, at selected health facilities in Ethiopia, 2016 – 2019. PLOS One. 2025. doi:10.1371/journal.pone.0338557

BibTeX
@article{Getahun2025,
  author = {Getahun, Muluwork and Kebede, Yenew and Molalegn, Hilina and Alemu, Ayinalem and Diriba, Getu and Sinshaw, Waganeh and Tadesse, Mengistu and Tesfaye, Ephrem and Belachew, Kassahun and Mekasha, Ameha and Feleke, Beniam},
  title = {Contribution of xpert MTB/RIF assay and Urine LF-LAM for the diagnosis of tuberculosis in children aged 5 – 14 years, at selected health facilities in Ethiopia, 2016 – 2019},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0338557}
}
Kostenlos starten →